WHWK Whitehawk Therapeutics, Inc. - Common Stock
$4.88
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026
52W Range
$2–$5
84% of range
Analyst Rating
BUY
14 analysts
Price Target
$8
+54% upside
P/E (TTM)
-14.8
ROE
-13.4%
Net Profit Margin
-288.3%
WHWK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.88
Market Cap
$230M
P/E (TTM)
-14.8
EPS (TTM)
$-0.33
Revenue (TTM)
$7M
Div Yield
—
ROE
-13.4%
Debt/Equity
—
52W Range
$2 – $5
WHWK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$7M
2018-12-31
→
2025-12-31
EPS
$-0.33
2021-12-31
→
2025-12-31
Free Cash Flow
$-98M
2018-12-31
→
2025-12-31
Margins
-288.3%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
WHWK
Peer Median
P/E (TTM)
-14.8
1.2
P/S (TTM)
32.2
6.3
P/B
1.7
1.6
Price / FCF
-2.4
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
WHWK
Peer Median
Operating Margin
-1601.1%
—
Net Profit Margin
-288.3%
-312.6%
ROA
-18.6%
-56.8%
ROE
-13.4%
-83.3%
ROIC
-83.9%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
WHWK
Peer Median
Current Ratio
10.3
8.5
Quick Ratio
10.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
WHWK
Peer Median
Revenue YoY
-72.5%
—
Revenue CAGR 3Y
-22.3%
—
Revenue CAGR 5Y
-12.6%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
WHWK
Peer Median
WHWK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 4 28.6%
- Buy 6 42.9%
- Hold 4 28.6%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-08-15
Median
$7.50
Now
$4.88
Low
$4.00
High
$10.00
Median target
$7.50
+53.7%
Mean target
$7.50
+53.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.25%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.20 | $-0.30 | 0.10% |
| March 31, 2026 | $-0.32 | $-0.36 | 0.04% |
| Dec. 31, 2025 | $-0.34 | $-0.16 | -0.18% |
| Sept. 30, 2025 | $-0.26 | $0.07 | -0.33% |
| June 30, 2025 | $-0.76 | $0.50 | -1.3% |
| March 31, 2025 | $-0.37 | $-0.47 | 0.10% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
Balance Sheet 25
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
Cash Flow 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
Valuation (TTM) 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
Income Statement 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | -116,042,087 | 69,204,899 | 69,083,127 | 39,640,826 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | -116,333,800 | 69,204,899 | 69,083,127 | 39,932,539 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
Balance Sheet 24
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
Cash Flow 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $7M | · | $14M | $21M | $26M | · | $25M | $24M | $23M | · | $22M | $20M | $16M | · | $10M | |
| Net Income TTM | $-109M | $-20M | · | $-10M | $-7M | $28M | · | $-62M | $-67M | $-68M | · | $-64M | $-66M | $-62M | · | $-134M | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -3.0 | 7.0 | · | 5.4 | 26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -1.9 | -2.5 | -2.6 | · | -1.2 | |
| P/S | · | 22.8 | · | 6.2 | 4.3 | 3.2 | · | 2.1 | 1.5 | 2.5 | · | 5.3 | 8.5 | 11.2 | · | 34.5 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| P / FCF | · | -7.3 | · | · | · | -6.7 | · | · | · | -2.8 | · | · | · | -7.8 | · | · | |
| Earnings Yield | -33.6% | 14.2% | · | 18.4% | 3.7% | 8.4% | · | -110.7% | -170.6% | -107.7% | · | -52.1% | -40.8% | -38.4% | · | -80.5% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M |
| Operating Margin % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M |
| Diluted EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 84 filers · $187.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 32 (+13 vs prior Q) | 11 (+7 vs prior Q) | 25 (+11 vs prior Q) | 12 (+4 vs prior Q) | +8.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Yu Fan | $22,264,818 | 4,861,314 | 11.87% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $21,461,477 | 4,685,912 | 11.44% | Shares |
| QVT Financial LP | $21,139,947 | 4,615,709 | 11.27% | Shares |
| MONTANOVA CAPITAL, LLC | $19,694,000 | 4,300,000 | 10.50% | Shares |
| ORBIMED ADVISORS LLC | $18,019,076 | 3,934,296 | 9.61% | Shares |
| Avoro Capital Advisors LLC | $13,050,261 | 2,849,402 | 6.96% | Shares |
| Siren, L.L.C. | $10,703,927 | 2,337,102 | 5.71% | Shares |
| KVP Capital Advisors, LP | $9,920,266 | 2,165,997 | 5.29% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $6,359,609 | 1,388,561 | 3.39% | Shares |
| ADAR1 Capital Management, LLC | $6,143,585 | 1,341,394 | 3.28% | Shares |
| ACORN CAPITAL ADVISORS, LLC | $5,218,283 | 1,139,363 | 2.78% | Shares |
| STEMPOINT CAPITAL LP | $4,676,349 | 1,021,037 | 2.49% | Shares |
| Ally Bridge Group (NY) LLC | $3,746,161 | 817,939 | 2.00% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,495,462 | 762,997 | 1.86% | Shares |
| Woodline Partners LP | $1,999,692 | 436,614 | 1.07% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,895,305 | 413,822 | 1.01% | Shares |
| STATE STREET CORP | $1,772,378 | 386,982 | 0.95% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,742,259 | 380,406 | 0.93% | Shares |
| Eversept Partners, LP | $1,389,141 | 303,306 | 0.74% | Shares |
| Verdad Advisers, LP | $1,380,792 | 301,483 | 0.74% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,358,483 | 296,612 | 0.72% | Shares |
| AMES NATIONAL CORP | $1,333,269 | 4,571 | 0.71% | Shares |
| Balyasny Asset Management L.P. | $1,319,576 | 288,117 | 0.70% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,130,834 | 246,907 | 0.60% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,004,014 | 219,217 | 0.54% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757,001 | 165,284 | 0.40% | Shares |
| VANGUARD GROUP INC | $519,881 | 214,827 | 0.28% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361,051 | 78,832 | 0.19% | Shares |
| GOLDMAN SACHS GROUP INC | $349,060 | 76,214 | 0.19% | Shares |
| Point72 Asset Management, L.P. | $261,651 | 57,129 | 0.14% | Shares |
| AMERICAN CENTURY COMPANIES INC | $237,427 | 51,840 | 0.13% | Shares |
| Qube Research & Technologies Ltd | $224,388 | 48,993 | 0.12% | Shares |
| UBS Group AG | $210,098 | 45,873 | 0.11% | Shares |
| Nuveen, LLC | $200,599 | 43,799 | 0.11% | Shares |
| Jump Financial, LLC | $186,864 | 40,800 | 0.10% | Shares |
| DEUTSCHE BANK AG\ | $145,039 | 31,668 | 0.08% | Shares |
| Bank of New York Mellon Corp | $132,623 | 28,957 | 0.07% | Shares |
| WELLS FARGO & COMPANY/MN | $124,457 | 27,174 | 0.07% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $123,761 | 27,022 | 0.07% | Shares |
| RHUMBLINE ADVISERS | $112,338 | 24,529 | 0.06% | Shares |
| Y-Intercept (Hong Kong) Ltd | $111,583 | 24,363 | 0.06% | Shares |
| TWO SIGMA ADVISERS, LP | $102,608 | 42,400 | 0.05% | Shares |
| Vanguard Global Advisers, LLC | $89,205 | 19,477 | 0.05% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $85,646 | 18,700 | 0.05% | Shares |
| BANK OF AMERICA CORP /DE/ | $85,518 | 18,672 | 0.05% | Shares |
| XTX Topco Ltd | $84,831 | 18,522 | 0.05% | Shares |
| CITADEL ADVISORS LLC | $79,440 | 17,345 | 0.04% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68,434 | 14,942 | 0.04% | Shares |
| ABG Innovation Capital Partners III GP Ltd | $64,532 | 26,666 | 0.03% | Shares |
| CITIGROUP INC | $60,209 | 13,146 | 0.03% | Shares |
| JPMORGAN CHASE & CO | $59,323 | 13,452 | 0.03% | Shares |
| Invesco Ltd. | $59,261 | 12,939 | 0.03% | Shares |
| EVERGREEN CAPITAL MANAGEMENT LLC | $50,380 | 11,000 | 0.03% | Shares |
| Scientech Research LLC | $49,638 | 10,838 | 0.03% | Shares |
| Police & Firemen's Retirement System of New Jersey | $46,739 | 10,205 | 0.02% | Shares |
| Quadrature Capital Ltd | $46,002 | 10,044 | 0.02% | Shares |
| TWO SIGMA SECURITIES, LLC | $45,951 | 10,033 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $31,804 | 6,944 | 0.02% | Shares |
| NORTHERN TRUST CORP | $23,239 | 5,074 | 0.01% | Shares |
| BARCLAYS PLC | $22,182 | 4,843 | 0.01% | Shares |
| US BANCORP \DE\ | $15,265 | 3,333 | 0.01% | Shares |
| Legal & General Group Plc | $14,482 | 3,162 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $13,488 | 2,945 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $11,880 | 2,594 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $11,702 | 2,555 | 0.01% | Shares |
| BlackRock, Inc. | $11,601 | 2,533 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $7,048 | 1,539 | 0.00% | Shares |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $6,105 | 1,333 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $5,000 | 1,114 | 0.00% | Shares |
| MORGAN STANLEY | $3,490 | 762 | 0.00% | Shares |
| Sterling Capital Management LLC | $2,995 | 654 | 0.00% | Shares |
| SATTER MANAGEMENT CO., L.P. | $2,079 | 659 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $1,452 | 317 | 0.00% | Shares |
| Quarry LP | $998 | 218 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $993 | 232 | 0.00% | Shares |
| FMR LLC | $779 | 170 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $778 | 170,883 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $664 | 145 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $604 | 132 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 26,609 | 0.00% | Shares |
| CWM, LLC | $86 | 25 | 0.00% | Shares |
| SIMPLEX TRADING, LLC | $82 | 18 | 0.00% | Shares |
| Virtu Financial LLC | $66 | 14,479 | 0.00% | Shares |
| Parallel Advisors, LLC | $37 | 8 | 0.00% | Shares |
Company insiders 24 insiders · 9 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David James Lennon | Chief Executive Officer | Oct. 2, 2023 A | — | 0 | 0 | $0 |
| Scott M. Giacobello | CFO, Interim CEO & President | April 3, 2023 A | 20,000 | 0 | 0 | $0 |
| Brendan Delaney | President and Chief Executive Officer | March 1, 2023 A | 20,000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | May 14, 2019 A | 31,967 | 0 | 0 | $0 |
| Joseph H. Gardner | President | March 16, 2020 A | 453,019 | 0 | 0 | $0 |
| Lorettta M Itri | Chief Medical Officer | March 1, 2023 A | — | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | March 16, 2020 A | 320,536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | May 14, 2019 A | — | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | Feb. 15, 2019 A | — | 0 | 0 | $0 |
| Baiteng Zhao | Director | June 12, 2026 A | — | 0 | 0 | $0 |
| Neil Desai | Director | June 12, 2026 A | 1,453,543 | 0 | 0 | $0 |
| Emma Reeve | Director | June 12, 2026 A | — | 0 | 0 | $0 |
| Mohammad Hirmand | Director | June 12, 2026 A | — | 0 | 0 | $0 |
| Anupam Dalal | Director | June 12, 2026 A | 4,685,912 | 0 | 0 | $0 |
| Richard E Maroun | Director | June 12, 2026 A | — | 0 | 0 | $0 |
| Caley Castelein | Director | June 12, 2026 A | 274,796 | 0 | 0 | $0 |
| Karin M. Hehenberger | Director | June 15, 2023 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Director | June 17, 2021 A | 8,020 | 0 | 0 | $0 |
| Chau Quang Khuong | Director | June 18, 2019 A | 5,193,946 | 0 | 0 | $0 |
| Satter Muneer A | Director | June 18, 2019 A | 5,621,835 | 0 | 0 | $0 |
| Paul M Weiss | Director | March 15, 2017 P | 1,576,167 | 0 | 0 | $0 |
| Dugel Pravin | — | June 30, 2021 A | 12,568 | 0 | 0 | $0 |
| Steven Prelack | — | June 30, 2021 A | 24,485 | 0 | 0 | $0 |
| Regina Marek | — | March 16, 2020 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 13 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 filings | May 18, 2026 | 9.00% | Amendment | Passive investment | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 filings | May 14, 2026 | 19.99% | Amendment | — | SEC |
| Neil Desai ×5 filings | March 6, 2025 | 4.90% | Amendment | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 filings | March 5, 2025 | 4.98% | Amendment | — | SEC |
| Muneer A. Satter (2) ×5 filings | Nov. 12, 2021 | — | Initial filing | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 filings | Sept. 3, 2021 | — | Initial filing | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 filings | May 15, 2020 | — | Initial filing | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 filings | Oct. 4, 2018 | — | Initial filing | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | March 27, 2017 | — | Initial filing | — | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | March 27, 2017 | — | Initial filing | — | SEC |
| Undisclosed reporting person | April 4, 2008 | — | Initial filing | — | SEC |
| Undisclosed reporting person | April 4, 2008 | — | Initial filing | — | SEC |
| Argyris Vassiliou | April 4, 2008 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 10 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.50% | 23,692 SH | Aug. 8, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 110,575 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 28,211 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.01% | 278,917 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 719,241 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 20,759 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 470,854 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 887,972 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 187,597 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,409 SH | Aug. 8, 2026 | Daily |